Výsledky vyhledávání

Akademický článek

Regulatory adaptive status in determining the effectiveness of treatment with bisoprololum and nebivololum in patients with paroxysmal atrial fibrillation and hypertension

Autor: M. A Eremina, V. G Tregubov, V. M Pokrovskiy

Publikováno v: КардиоСоматика, Vol 9, Iss 1, Pp 10-16 (2018)

Increase in mortality from cardiovascular causes, systemic thromboembolism, congestive heart failure, increased frequency of hospitalization and deterioration in quality of life is associated with atrial fibrillation (AF). Essential hypertension (EH)

Externí odkaz: https://doaj.org/article/bcc47ca73e264c39bcf9f3ac7e3766dd

Zobrazit plný text záznamu

Akademický článek

Regulatory adaptive status in determining the effectiveness of nebivololum and sotalolum in patients with hypertensive disease and paroxysmal supraventricular tachycardia

Autor: N M Nazhalkina, V G Tregubov, V M Pokrovsky

Publikováno v: Системные гипертензии, Vol 14, Iss 4, Pp 20-26 (2017)

Objective. Compare the effectiveness of treatment with nebivololum or sotalolum in patients with paroxysmal supraventricular tachycardia (SVT) on a background of essential hypertension (EH) taking into account quantitative evaluation of the regulator

Externí odkaz: https://doaj.org/article/0af0c329b82b4880952f0d92ed836fa6

Zobrazit plný text záznamu

Akademický článek

Regulatory adaptive status in determining the effectiveness of nebivololum and sotalolum in patients with hypertensive disease and paroxysmal supraventricular tachycardia

Autor: Nazhalkina N.M., Tregubov V.G., Pokrovsky V.M.

Publikováno v: Системные гипертензии, Vol 14, Iss 4, Pp 20-26 (2017)

Externí odkaz: https://doaj.org/article/a30b5d14e6af430da2d0f498f9e93d47

Zobrazit plný text záznamu

Akademický článek

Regulatory adaptive status in determining the effectiveness of nebivololum and sotalolum in patients with hypertensive disease and paroxysmal atrial fibrillation

Autor: M A Eremina, V G Tregubov, V M Pokrovsky

Publikováno v: Системные гипертензии, Vol 13, Iss 4, Pp 30-35 (2016)

Aim: compare the effectiveness of treatment with nebivololum or sotalolum in patients with hypertensive disease (HD) and paroxysmal atral fibrillation (AF) taking into account quantitative evaluation of the regulatory adaptive status (RAS). Materials

Externí odkaz: https://doaj.org/article/1d973402915c454aa06e5cab58a67c4d

Zobrazit plný text záznamu